Previous 10 | Next 10 |
2023-05-10 21:30:03 ET BioLife Solutions, Inc. (BLFS) Q1 2023 Earnings Conference Call May 10, 2023, 16:30 ET Company Participants Troy Wichterman - CFO Michael Rice - Chairman & CEO Conference Call Participants Jacob Johnson - Stephens Inc. Thoma...
2023-05-10 16:23:25 ET BioLife Solutions press release ( NASDAQ: BLFS ): Q1 GAAP EPS of -$0.32 misses by $0.11 . Revenue of $37.7M (+4.1% Y/Y) misses by $5.24M . We remain confident that we will achieve Q4 2024 run rate aspirational financial goals of $250 mill...
BioLife Solutions Reports First Quarter 2023 Financial Results PR Newswire Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28% Q1 2023 Adjusted gross margin improvement; 37% compared to 32% in Q...
BioLife Solutions to Provide First Quarter 2023 Financial Results and Business Update on May 10, 2023 PR Newswire BOTHELL, Wash. , May 2, 2023 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools a...
2023-03-28 12:08:15 ET Summary BioLife Solutions, a leading provider of bioproduction tools and services, is poised for growth as the demand for biologics and regenerative medicine increases. CryoStor and HypoThermosol have shown significant improvement to the post-preservation vi...
2023-03-25 07:51:54 ET Summary An acquisition spree has produced a host of problems, costs, write-offs, a collapse in gross margins and profits, cash bleed, and significant dilution. While only the evo and Sexton acquisitions have been a real success, the problems at some of the o...
2023-03-16 21:55:22 ET BioLife Solutions, Inc. (BLFS) Q4 2022 Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Troy Wichterman – Chief Financial Officer Mike Rice – Chairman and Chief Executive Officer Conference Call Partic...
2023-03-16 16:04:52 ET BioLife Solutions press release ( NASDAQ: BLFS ): Q4 GAAP EPS of -$1.15 misses by $0.99 . Revenue of $44.26M (+18.7% Y/Y) beats by $0.94M . Cell Processing platform revenue was $20.2 million, up $5.3 million, or 36%, over the same period ...
BioLife Solutions Reports Preliminary and Unaudited 2022 Fourth Quarter and Full Year Financial Results PR Newswire Record full year revenue of $161.8 million increased 36% over 2021; biopreservation media revenue growth of 45%, validating leading position as a critical ce...
2023-03-15 17:35:35 ET Major earnings expected after the bell on Thursday include: FedEx Corporation ( FDX ) HEXO Corp. ( HEXO ) Geron Corporation ( GERN ) Eastman Kodak ( KODK ) Meta Materials ( MMAT ) For further details see: Notable ear...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...